{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: We conclude that : 1 ) administration of rhIGF - I improves growth and GFR in rats with chronic PAN nephropathy and 2 ) unlike rhGH , long - term use of rhIGF - I does not worsen renal functional and structural injury in this disease model .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| chronic PAN nephropathy |\n| this disease model (refers to chronic PAN nephropathy) |\n\nExplanation:\n\n* \"chronic PAN nephropathy\" is a specific disease mentioned in the paragraph.\n* \"this disease model\" is a phrase that refers to the specific disease mentioned earlier in the paragraph, which is chronic PAN nephropathy."},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| chronic PAN nephropathy |\n\nExplanation:\n\n* \"chronic PAN nephropathy\" is the only clear and specific disease mentioned in the paragraph.\n* \"this disease model\" is a phrase that refers to the specific disease mentioned earlier in the paragraph, which is chronic PAN nephropathy. However, since the specific disease is already mentioned in the previous point, it is not necessary to include \"this disease model\" as a separate entity."}
  ],
  "Chemical": [
    {"role": "user", "content": "Please identify the \"Chemical\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Chemical\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: We conclude that : 1 ) administration of rhIGF - I improves growth and GFR in rats with chronic PAN nephropathy and 2 ) unlike rhGH , long - term use of rhIGF - I does not worsen renal functional and structural injury in this disease model .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| rhIGF - I |\n| GFR |\n| chronic PAN nephropathy |\n| rhGH |\n\nExplanation:\n\n* rhIGF - I: recombinant human Insulin-like Growth Factor - I\n* GFR: Glomerular Filtration Rate\n* chronic PAN nephropathy: a disease model, where PAN stands for Pasireotide, an analog of somatostatin\n* rhGH: recombinant human Growth Hormone"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Chemical\" and present the valid entities as a Markdown table with one column \"Chemical\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Chemical |\n| --- |\n| rhIGF - I |\n| GFR |\n| rhGH |\n\nExplanation:\n\n* rhIGF - I: recombinant human Insulin-like Growth Factor - I\n* GFR: Glomerular Filtration Rate\n* rhGH: recombinant human Growth Hormone\n\nThe term \"chronic PAN nephropathy\" is not a chemical entity, it is a disease model."}
  ]
}